Learn more about PRIMA as a treatment for vision loss from certain retinal diseases
Join the Patient Registry
If you or someone you know has been diagnosed with age-related macular degeneration, retinitis pigmentosa, or Stargardt disease, please consider joining our patient registry for retinal diseases.
Join the RegistryMedical Professional Network
Sign up to learn more details about PRIMA's mechanism of action, the surgical implant technique, and latest updates on PRIMA’s approval for implantation in patients.
Join our professional networkMore about Science Corporation
Learn more about PRIMA and Science Corporation’s suite of neural engineering and brain computer interface (BCI) technologies.
Get UpdatesCAUTION: Investigational device. Limited by federal law to investigational use. Hardware shown is for display purposes only. Actual device shape and color may vary.
Science PRIMA bypasses lost photoreceptors and stimulates the remaining cells in the retina with two components:
A small light-powered implant designed to replace the function of light-sensitive cells
A special pair of glasses sends light signals to the implant, providing both power and data.
